October E-learn Call: Visual Design for

Powerful Presentations

Sophy Wong (East Bay AETC)

ObjectivesBy the end of this session, participants will be able to:• Discuss and practice using 3 visual presentation

design principles• Evaluate 2 example presentation slides and

recommend 2 ways to increase their visual impact• Create your own awesome, high-impact slide

for Powerful Presentations!

Sophy Wong, MD

objectives

process & principles

slide makeovers

design a good slide

simplicity

focus

objectives

process & principles

slide makeovers

design a good slide

1. focus

high impact visuals

clear fonts

dark on light

(very) light on dark

empty space

2. repetition

same fontssame colorssame design

slide master

slide master

Does this enhance my central point?

…or does this?

3. alignment

Keep it togethertext boxestablesgrids

objectives

process & principles slide makeovers design a good slide

•bullet•point •makeover

Potential Benefits of Early Therapy (CD4 count >500 cells/µL)

Cohort study data show survival benefit if ART initiated at CD4 count >500 cells/µL

Earlier ART may prevent HIV-related end organ damage; deferred ART may not reliably repair damage acquired earlier Increasing evidence of direct HIV effects on

various end organs and indirect effects via HIV-associated inflammation

End organ damage occurs at all stages of infection

October 2011 www.aidsetc.org32

Potential Benefits of Early Therapy (CD4 count >500 cells/µL) (2)

Potential decrease in risk of many complications, including: HIV-associated nephropathy Liver disease progression from hepatitis B or

hepatitis C Cardiovascular disease Malignancies (AIDS defining and non-AIDS

defining) Neurocognitive decline Blunted immunological response owing to

ART initiation at older age Persistent T-cell activation and inflammationOctober 2011 www.aidsetc.org33

Potential Benefits of Early Therapy (CD4 count >500 cells/µL) (3)

Prevention of sexual and bloodborne transmission of HIV

Prevention of mother-to-child transmission of HIV

October 2011 www.aidsetc.org34

Potential Limitations of Early Therapy (CD4 count >500 cells/µL)

ARV-related toxicities Drug resistance Nonadherence to ART Cost

October 2011 www.aidsetc.org35

When to start

↑CD4

+stay healthy

transmission

-adherenceOIs

-drug toxicity-resistance

-lack of options

graph makeover

what is this?

can't read

0 1 2 3 4 5 6 7 8 9

busyugly3D

Source: Centers for Disease Control and Prevention (CDC). eHARS. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [2006-2010].

Percentage of Newly Reported HIV (non-AIDS) Cases By Race/Ethnicity, Alameda County 2006-2010

HIV by race/ethnicity, 2008

http://www.dhcs.ca.gov/Pages/HepatitisC.aspx

CA hep C treatment algorithm:handout!

Getty Images

Shutterstock.com

CA hep C treatment algorithm

mild liver disease

wait

objectives

process & principles slide makeovers design a good slide

1. master slide2. title slide3. data slide

start fresh & focus

Questions?

Contact

Any questions about the presentation:

Sophy Wong: sophy.wong@ucsf.edu